CorMedix (CRMD) Revenue (2013 - 2025)

CorMedix has disclosed Revenue across 12 years of filings, most recently posting $128.6 million for Q4 2025.

• Revenue for Q4 2025 came in at $128.6 million, up 312.1% year-over-year; the trailing twelve-month figure through Dec 2025 was $311.7 million (up 616.54% YoY), and the FY2025 annual result was $311.7 million, up 617.03% from the prior year.
• Revenue came in at $128.6 million for Q4 2025 at CorMedix, up from $104.3 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $128.6 million in Q4 2025 to a low of $6817.0 in Q3 2022.
• The 4-year median for Revenue is $88261.0 (2021), against an average of $23.7 million.
• Across the five-year window, Revenue tumbled 91.35% in 2022 and surged 4829.4% in 2025, its largest moves.
• CorMedix's Revenue stood at $56397.0 in 2021, then sank by 47.33% to $29702.0 in 2022, then surged by 104976.31% to $31.2 million in 2024, then soared by 312.1% to $128.6 million in 2025.
• The last three Revenue figures came in at $128.6 million (Q4 2025), $104.3 million (Q3 2025), and $39.7 million (Q2 2025), per Business Quant data.